BRAF and melanoma: Two of the BRCA CDx devices are produced by Myriad Genetic Laboratories, Inc. and the other two by Foundation Medicine, Inc. Therefore, Foundation Medicine, Inc., the manufacturer of FoundationOne CDx discussed above for detection of BRAF V600E in patients with melanoma, which is now versed in therapeutic class labeling, could reasonably seek therapeutic class labeling for these additional devices as well.